Skip to main content
Caplight Logo









Ubiquigent Limited

Ubiquigent Limited

Private
DundeeHealthcare & Life Scienceshttps://ubiquigent.com/

Last Round

Grant

Jan 14, 2021

Total Funding Raised

$5.32M

Company Overview

Ubiquigent Limited is a biotechnology company that provides drug discovery services and develops novel deubiquitinase (DUB) modulators as therapeutics for areas of high unmet medical need.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Non-AI

Keywords

ubiquitin-proteasome systemUPStargeted protein degradationdeubiquitylaseDUBdrug discovery servicescontract research organizationCRODUBprofilerproteolysis targeting chimeraPROTACsmall molecule therapeuticschemical biology toolsassay developmentbiotech research partner

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ubiquigent Limited Comparables

Compare Ubiquigent Limited with similar companies based on industry and business-model similarity.

Ubiquigent Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeSensors, Inc.
86%
Progenra, Inc.
83%
Trilogie Bioscience
81%

Ubiquigent Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 14, 2021
SeedSep 18, 2013
Corporate FundingMar 10, 2010

Ubiquigent Limited Investors

Notable investors and investment history

Ubiquigent Limited investors
InvestorRounds
IP GroupSeed
UKRI Innovate UKGrant
Scottish Investment Bank (Scottish Enterprise)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2013

    $790K round with IP Group and Scottish Investment Bank

  • Mar 10, 2010

    $4.53M round led by ReproCELL Incorporated

Ubiquigent Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ubiquigent Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ubiquigent Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersDundee
Employee Range1
Year Founded2009
Last FundingJan 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?